Saturday, March 14, 2015 6:03:52 PM
Since the approval for medical uses of anything is a long and arduous process, i could easily see Kim creating a spin-off company when he gets to that point to minimize the cost to KBLB.
I do agree that Kim and Jon need to focus on the mundane first and worry about Gen 3 fiber development after. From the same conference call:
How far along he is in the development of Gen 2, or pure spider silk, is still unknown. I mentioned in an earlier post that I suspected that Big Red may end up becoming SpiderPillar. That old conference call reinforces this with:
Advanced stage of development in 2012 should mean beginning ramp up to commercialization in the near future which should ideally mean full commercialization in 2017 or so with no issues. This may be accelerated by increased funding due to MS commercialization and a dedicated sericulture facility.
That Cocoon Biotech company is news to me. Thanks for posting it. Just a quick glance over the website shows that they are using standard silk. They may be processing it to give it better properties or maybe plan to eventually alter the silkworms, though. I noticed that David Kaplan is one of their advisors, so it would be a possibility. Just standard silk properties is a little weak compared to what would be required for tendon replacement or sutures.
I know for a fact that Kim is not the only one keeping secrets. There are plenty of scientists out there that are working on new, advanced methods for spider silk production to eventually create their own company or license it out mand get in on the imminant new revolution in biofibers and other biomaterials.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM